TRIPASS XR تري باس

 

5

2

6

S

u

l

fo

n

a

m

i

d

e

s

,

2

1

3

1

t

a

n

d

A

I

N

,

6

4

5

a

dv

e

r

s

e

e

ffe

c

t

s

o

f,

1

3

3

3

t

fo

r

R

M

S

F

,

1

7

2

5

S

u

l

fo

n

yl

u

r

e

a

,

5

5

,

1

1

1

7

–

1

1

2

3

a

dv

e

r

s

e

e

ffe

c

t

s

o

f,

1

1

2

2

–

1

1

2

3

c

o

ntr

a

in

dic

a

t

io

n

s

a

n

d

p

r

e

c

a

ut

io

n

s

o

f,

1

1

2

3

fo

r

dia

b

e

t

e

s

,

1

6

7

do

s

a

g

e

a

n

d

c

linic

a

l

u

s

e

o

f,

1

1

2

3

drug

int

e

r

a

c

t

io

n

s

o

f,

1

1

2

3

e

ffic

a

c

y

o

f,

1

1

2

3

me

c

h

a

nis

m

o

f

a

c

t

io

n

,

1

1

2

2

p

h

a

r

ma

c

o

kin

e

t

ic

s

o

f,

1

1

2

2

Sulindac, 637, 870t, 888t

Sulisobenzone, 849t

Sumatriptan, 1237–1238, 1238t, 1240, 1243–1244

adverse effects of, 1238

drug interactions of, 1238

Sunitinib, 470t, 1977, 1990

and hypertension, 1990

Sunscreen, 827, 830, 831

Suppressive therapy, 1601

2002 USPHS/IDSA guidelines, 1601

for Toxoplasma encephalitis, 1606

Suprax (see Cefixime)

Surface-active agents

for GER, 2163–2164, 2163t

Sutent (see Sunitinib)

Suvorexant (Belsomra), 1767t, 1770

Symbicort (see Budesonide/formoterol)

Symmetrel (see Amantadine)

Synarel (see Nafarelin)

Synthetic conjugated estrogens (Enjuvia), 1033t

Systemic agents, 1624t

antifungals, 1629t

Systemic antihistamines, 819

T

Tabloid (see Thioguanine)

Tacrine, 942t

drug interaction with smoking, 1906t

Tacrolimus, 120t, 721–722, 819, 820, 942t

in liver transplantation, 736–737

Tadalafil, 2265

for BPH, 2257

and ED, 2265

Tafluprost (Zioptan), 1151, 1152

Talc, 1627

Talinolol, 128

Tamiflu (see Oseltamivir)

Tamoxifen, 1972

Tamsulosin, 2256

for BPH, 2256

Tannic acid, 1626

Tanning pills, 856

Tapazole (see Methimazole)

Tarceva (see Erlotinib)

Tasigna (see Nilotinib)

Tasimelteon, 1906t

Tasmar (see Tolcapone)

Tauroursodeoxycholic acid, 765

Tavist (see Clemastine)

Taxanes, 1981t

for prostate cancer, 2094

Taxol (see Paclitaxel)

Tazarotene, 827, 829, 858

for psoriasis, 835t, 838

Tazobactam, 491t

for cystic fibrosis, 461t

TDF (see Tenofovir Disoproxil Fumarate (TDF))

Tedizolid (Sivestro), 1325t

adverse effects of, 1333t

for aerobic gram-positive cocci, 1326t

Teflaro (see Ceftaroline)

Tegaserod, 534

Telaprevir, 120t, 128, 914t, 1686

for HAV, 1687

Telavancin (Vibativ), 1326t, 1393, 1419

adverse effects of, 1333t

for skin and soft tissue infections, 1549

Telbivudine, 1680

Televancin, 1326t

Telithromycin, 120t, 128

adverse effects of, 1333t

Telithromycin (Ketek), 1325t

Telmisartan, 154t

Temazepam (Restoril), 1737t, 1768, 1772–1773

for LTCF, 2229

and sleep, 1774

for treatment of insomnia, 1767t

Temodar (see Temozolamide)

Temozolamide (Temodar), 469t

Temozolomide, 470t

Temsirolimus, 469t, 1990

Tenecteplase (TNK), 237

Teniposide, 1979t

Tenofovir, 673

Tenofovir alafenamide, 1678, 1679–1680

Tenofovir Disoproxil Fumarate (TDF), 1577t

Tenofovir disoproxil fumarate, 1678, 1679

Terazosin, 157t, 2256, 2261t

for BPH, 2256

in patients with CKD, 617

Terbinafine, 1624t, 1628

Terconazole, 1525t, 1624t

Teriflunomide, 1223, 1230

Teriparatide, 2277t, 2286

Terlipressin, 547–548, 554–555

Tesofensine, 765

Tetracaine, 1177t

Tetracycline, 493–494t, 1325t

GERD and, 503t

Tetracyclines, 484, 496–497, 828, 830, 942t, 1720

adverse effects of, 1333t

and dyspepsia, 487

for osteoporosis, 2274

for RMSF, 1725

for TBRF, 1725

teratogenic effects, 973t

for tularemia, 1725

TGC (see Third-generation cephalosporin (TGC))

Thalidomide, 470t, 1972, 2037t

peripheral nerve toxicity of, 1986

t

e

r

a

t

o

g

e

nic

e

ffe

c

t

s

,

9

7

3

t

T

h

a

l

o

m

i

d

(

s

e

e

T

h

a

l

i

d

o

m

i

d

e

)

T

h

e

o

p

h

yl

l

i

n

e

,

4

8

4

,

4

8

5

,

4

8

6

,

4

8

7

,

9

1

7

t